Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Sameem Abedin MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Bone Marrow Transplant

Member of the Cancer Center

View Curriculum Vitae

Research Experience

  • Adult
  • Humans

    • Clinical Expertise

  • Adult
  • Bone Marrow Transplantation
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes

    • Publications (42)

  • Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia. (Abedin SM, Badar T, Gauger K, Michaelis LC, Runaas L, Carlson KS, Murthy GG, Atallah E) Leuk Res 2022 Dec;123:106984 PMID: 36401944 SCOPUS ID: 2-s2.0-85141943453 11/20/2022    
  • Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]. (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Transplant Cell Ther 2022 Oct;28(10):717 PMID: 36202527 SCOPUS ID: 2-s2.0-85101258094 10/07/2022    
  • Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885, (S1083879120304146), (10.1016/j.bbmt.2020.07.005)] (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Transplantation and Cellular Therapy October 2022;28(10):717 SCOPUS ID: 2-s2.0-85101258094 10/01/2022    
  • Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome. (Corrao K, Rezwan S, Atallah E, Michaelis LC, Runaas L, Harrington AM, Abedin S) Leuk Res Rep 2022;17:100329 PMID: 35651540 PMCID: PMC9150024 SCOPUS ID: 2-s2.0-85131561638 06/03/2022    
  • Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients. (Abid MB, Rubin M, Ledeboer N, Szabo A, Longo W, Mohan M, Shah NN, Fenske TS, Abedin S, Runaas L, D'Souza A, Chhabra S, Dhakal B, Hamadani M) Cancer Cell 2022 Apr 11;40(4):340-342 PMID: 35202585 PMCID: PMC8864440 SCOPUS ID: 2-s2.0-85127542763 02/25/2022       12 Citations
  • Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies. (Mohan M, Nagavally S, Shah N NN, Michaelis L, Chhabra S, Souza AD, Abedin S, Runaas L, Guru Murthy GS, Longo W, Hamadani M, Dhakal B, Hari P, Fenske TS) Clin Lymphoma Myeloma Leuk 2022 Jul;22(7):e495-e497 PMID: 35148976 PMCID: PMC8767926 SCOPUS ID: 2-s2.0-85132179962 02/13/2022       1 Citation
  • Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study. (Kunte S, Rybicki L, Viswabandya A, Tamari R, Bashey A, Keyzner A, Iqbal M, Grunwald MR, Dholaria B, Elmariah H, Ozga M, Singh A, Abedin S, DeZern AE, Jones RJ, Gupta V, Gerds AT, Jain T) Leukemia 2022 Mar;36(3):856-864 PMID: 34663912 SCOPUS ID: 2-s2.0-85117218470 10/20/2021       10 Citations
  • Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy. (Dhakal B, Abedin S, Fenske T, Chhabra S, Ledeboer N, Hari P, Hamadani M) Blood 2021 Oct 07;138(14):1278-1281 PMID: 34339501 PMCID: PMC8332674 SCOPUS ID: 2-s2.0-85114112109 08/03/2021       62 Citations
  • Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis. (Abedin S, Rashid N, Schroeder M, Romee R, Nauffal M, Alhaj Moustafa M, Kharfan-Dabaja MA, Palmer J, Hogan W, Hefazi M, Larson S, Holtan S, DeFilipp Z, Jayani R, Dholaria B, Pidala J, Khimani F, Grunwald MR, Butler C, Hamadani M) Br J Haematol 2021 Nov;195(3):429-432 PMID: 34254289 PMCID: PMC9293486 SCOPUS ID: 2-s2.0-85109689194 07/14/2021       2 Citations
  • Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease. (Abedin S, Hamadani M) J Exp Pharmacol 2020;12:549-557 PMID: 33273867 PMCID: PMC7705269 SCOPUS ID: 2-s2.0-85097884873 12/05/2020       4 Citations
  • Bronchoalveolar lavage-based COVID-19 testing in patients with cancer. (Abid MB, Chhabra S, Buchan B, Graham MB, Abedin S, Thapa B, D'Souza A, George B, Hamadani M) Hematol Oncol Stem Cell Ther 2021 Mar;14(1):65-70 PMID: 33058787 PMCID: PMC7543702 SCOPUS ID: 2-s2.0-85092735525 10/16/2020       12 Citations
  • Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. (Mushtaq MU, Harrington AM, Chaudhary SG, Michaelis LC, Carlson KB, Abedin S, Runass L, Callander NS, Fallon MJ, Juckett M, Hall AC, Hematti P, Mattison RJ, Atallah EL, Guru Murthy GS) Leuk Lymphoma 2021 Jan;62(1):158-166 PMID: 32951486 SCOPUS ID: 2-s2.0-85091139710 09/22/2020       7 Citations
  • Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2020 Oct;26(10):1876-1885 PMID: 32653622 PMCID: PMC7571859 SCOPUS ID: 2-s2.0-85089134303 07/13/2020       1 Citation
  • Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase—A real world study (George G, Rezazadeh A, Zook F, Pearl N, McCoy C, Carlson K, Runaas L, Abedin S, Guru Murthy GS, Michaelis LC, Atallah E, Baumann-Kreuziger L) Leukemia Research July 2020;94 SCOPUS ID: 2-s2.0-85084755644 07/01/2020       2 Citations
  • Letter to the Editor Regarding "Diagnostic Considerations for COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplantation". (Chhabra S, Abedin S, Graham MB, Ferrer Marrero TM, Hari PN, Shaw BE) Biol Blood Marrow Transplant 2020 Sep;26(9):e241-e242 PMID: 32589922 PMCID: PMC7309826 SCOPUS ID: 2-s2.0-85087728830 06/27/2020       1 Citation
  • Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation. (Abid MB, Hamadani M, Szabo A, Hari PN, Graham MB, Frank MO, Collier WS, Abedin S, Jerkins JH, Pasquini MC, Runaas L, Shah NN, Chhabra S) Biol Blood Marrow Transplant 2020 Sep;26(9):1670-1678 PMID: 32562858 SCOPUS ID: 2-s2.0-85087739042 06/21/2020       10 Citations
  • Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase-A real world study. (George G, Rezazadeh A, Zook F, Pearl N, McCoy C, Carlson K, Runaas L, Abedin S, Guru Murthy GS, Michaelis LC, Atallah E, Baumann-Kreuziger L) Leuk Res 2020 Jul;94:106368 PMID: 32442786 SCOPUS ID: 2-s2.0-85084755644 05/23/2020       2 Citations
  • Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease. (Abedin SM, Hamadani M) Expert Opin Investig Drugs 2020 May;29(5):423-427 PMID: 32293938 SCOPUS ID: 2-s2.0-85083651597 04/16/2020       6 Citations
  • Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database. (Guru Murthy GS, Szabo A, Michaelis L, Carlson KS, Runaas L, Abedin S, Atallah E) J Natl Compr Canc Netw 2020 Feb;18(2):169-175 PMID: 32023530 SCOPUS ID: 2-s2.0-85079065513 02/06/2020       17 Citations
  • Inhibitory effects of SEL201 in acute myeloid leukemia. (Kosciuczuk EM, Kar AK, Blyth GT, Fischietti M, Abedin S, Mina AA, Siliezar R, Rzymski T, Brzozka K, Eklund EA, Beauchamp EM, Eckerdt F, Saleiro D, Platanias LC) Oncotarget 2019 Dec 24;10(67):7112-7121 PMID: 31903169 PMCID: PMC6935253 SCOPUS ID: 2-s2.0-85077552456 01/07/2020       10 Citations
  • Natural killer cell activity and survival after azacitidine treatment in high-risk MDS. (Abedin SM, Platanias LC) Leuk Lymphoma 2019 Oct;60(10):2343-2344 PMID: 31120354 SCOPUS ID: 2-s2.0-85066879883 05/24/2019    
  • Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation. (Abedin S, McKenna E, Chhabra S, Pasquini M, Shah NN, Jerkins J, Baim A, Runaas L, Longo W, Drobyski W, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2019 Aug;25(8):1689-1694 PMID: 30965140 SCOPUS ID: 2-s2.0-85065022222 04/10/2019       52 Citations
  • Myeloid malignancies after treatment for solid tumours. (Guru Murthy GS, Abedin S) Best Pract Res Clin Haematol 2019 Mar;32(1):40-46 PMID: 30927974 SCOPUS ID: 2-s2.0-85062663467 04/01/2019       6 Citations
  • Leukemoid reaction in chronic myelomonocytic leukemia patients undergoing surgery: perioperative management recommendations. (Patel AB, Pettijohn EM, Abedin SM, Raps E, Deininger MW) Blood Adv 2019 Apr 09;3(7):952-955 PMID: 30923049 PMCID: PMC6457233 SCOPUS ID: 2-s2.0-85068307348 03/30/2019       7 Citations
  • Inhibitory effects of SEL201 in acute myeloid leukemia (Kosciuczuk EM, Kar AK, Blyth GT, Fischietti M, Abedin S, Mina AA, Siliezar R, Rzymski T, Brzozka K, Eklund EA, Beauchamp EM, Eckerdt F, Saleiro D, Platanias LC) Oncotarget 2019;10(67):7112-7121 SCOPUS ID: 2-s2.0-85077552456 01/01/2019       10 Citations
  • Identification and targeting of novel CDK9 complexes in acute myeloid leukemia. (Beauchamp EM, Abedin SM, Radecki SG, Fischietti M, Arslan AD, Blyth GT, Yang A, Lantz C, Nelson A, Goo YA, Akpan I, Eklund EA, Frankfurt O, Fish EN, Thomas PM, Altman JK, Platanias LC) Blood 2019 Mar 14;133(11):1171-1185 PMID: 30587525 PMCID: PMC6418475 SCOPUS ID: 2-s2.0-85062974965 12/28/2018       18 Citations
  • Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. (Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M) Biol Blood Marrow Transplant 2019 Apr;25(4):827-833 PMID: 30572109 SCOPUS ID: 2-s2.0-85059680507 12/21/2018       15 Citations
  • Incidence and survival of T-cell acute lymphoblastic leukemia in the United States. (Guru Murthy GS, Pondaiah SK, Abedin S, Atallah E) Leuk Lymphoma 2019 May;60(5):1171-1178 PMID: 30407885 SCOPUS ID: 2-s2.0-85057299329 11/09/2018       16 Citations
  • Incorporating newer agents in the treatment of acute myeloid leukemia. (Raj RV, Abedin SM, Atallah E) Leuk Res 2018 Nov;74:113-120 PMID: 30401522 SCOPUS ID: 2-s2.0-85055577100 11/08/2018       7 Citations
  • Implications of high EVI1 expression in high-risk myelodysplastic syndromes. (Abedin S, Platanias LC) Leuk Lymphoma 2018 Dec;59(12):2765-2766 PMID: 29718736 SCOPUS ID: 2-s2.0-85046464614 05/03/2018    
  • Circulating microRNAs: promising biomarkers in aplastic anemia. (Bell JB, Abedin S, Platanias LC) Haematologica 2017 Jan;102(1):1-2 PMID: 28040785 PMCID: PMC5210225 SCOPUS ID: 2-s2.0-85008339555 01/04/2017    
  • Acute promyelocytic leukemia: preventing early complications and late toxicities. (Abedin S, Altman JK) Hematology Am Soc Hematol Educ Program 2016 Dec 02;2016(1):10-15 PMID: 27913456 PMCID: PMC6142484 SCOPUS ID: 2-s2.0-85021848968 12/04/2016       28 Citations
  • PD1 and PDL1 upregulation and survival after decitabine treatment in lower risk MDS. (Abedin S, Platanias LC) Leuk Lymphoma 2017 Apr;58(4):764-765 PMID: 27808592 SCOPUS ID: 2-s2.0-84994086261 11/04/2016       4 Citations
  • BET inhibitors in the treatment of hematologic malignancies: current insights and future prospects. (Abedin SM, Boddy CS, Munshi HG) Onco Targets Ther 2016;9:5943-5953 PMID: 27729803 PMCID: PMC5047722 SCOPUS ID: 2-s2.0-84989325811 10/13/2016       44 Citations
  • Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo. (Kosciuczuk EM, Saleiro D, Kroczynska B, Beauchamp EM, Eckerdt F, Blyth GT, Abedin SM, Giles FJ, Altman JK, Platanias LC) Blood 2016 Jul 21;128(3):410-4 PMID: 27307295 PMCID: PMC4957163 SCOPUS ID: 2-s2.0-85020242145 06/17/2016       31 Citations
  • Whole-exome sequencing for relapse prediction in patients discontinuing TKI treatment in chronic myeloid leukemia. (Abedin S, Platanias LC) Leuk Lymphoma 2016 Jul;57(7):1503-4 PMID: 26915266 SCOPUS ID: 2-s2.0-84959226022 02/27/2016       1 Citation
  • Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung. (Abedin S, Yanik GA, Braun T, Pawarode A, Magenau J, Goldstein SC, Levine JE, Kitko CL, Couriel DR) Biol Blood Marrow Transplant 2015 Jun;21(6):1127-31 PMID: 25687798 PMCID: PMC4970454 SCOPUS ID: 2-s2.0-84947490863 02/18/2015       33 Citations
  • Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation. (Abedin S, Peres E, Levine JE, Choi S, Yanik G, Couriel DR) Biol Blood Marrow Transplant 2014 Dec;20(12):2062-6 PMID: 25046834 PMCID: PMC4291068 SCOPUS ID: 2-s2.0-84912100424 07/22/2014       8 Citations
  • Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis. (Dvergsten JA, Mueller RG, Griffin P, Abedin S, Pishko A, Michel JJ, Rosenkranz ME, Reed AM, Kietz DA, Vallejo AN) Arthritis Rheum 2013 Aug;65(8):2201-10 PMID: 23686519 PMCID: PMC3729743 SCOPUS ID: 2-s2.0-84881360848 05/21/2013       26 Citations
  • EF-G-dependent GTPase on the ribosome. conformational change and fusidic acid inhibition. (Seo HS, Abedin S, Kamp D, Wilson DN, Nierhaus KH, Cooperman BS) Biochemistry 2006 Feb 28;45(8):2504-14 PMID: 16489743 SCOPUS ID: 2-s2.0-33644542727 02/24/2006       67 Citations
  • Can ultrasonography or uroflowmetry predict which children with voiding dysfunction will have recurrent urinary tract infections? (Shaikh N, Abedin S, Docimo SG) J Urol 2005 Oct;174(4 Pt 2):1620-2; discussion 1622 PMID: 16148667 SCOPUS ID: 2-s2.0-24944553427 09/09/2005       23 Citations
  • Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. (Abedin S, Michel JJ, Lemster B, Vallejo AN) Exp Gerontol 2005 Jul;40(7):537-48 PMID: 16002251 SCOPUS ID: 2-s2.0-23044510924 07/09/2005       55 Citations
    • Last update: 03/02/2023